EyePoint Pharmaceuticals Inc. (EYPT), which reported positive interim 16-week data from its phase II VERONA clinical trial last ...

since previous work found that repeat expansions in the range of 30 to 100 CAGs were necessary — but not sufficient — to cause Huntington’s. McCarroll agreed that 100 or fewer CAGs are not ...

since previous work found that repeat expansions in the range of 30 to 100 CAGs were necessary — but not sufficient — to cause Huntington’s. McCarroll agreed that 100 or fewer CAGs are not ...

today announced that the first patient has been dosed in the OCU200 Phase 1 clinical trial for diabetic macular edema (DME). “OCU200 has the potential to change the treatment landscape for DME ...

Genome-wide association analyses identify distinct genetic architectures for age-related macular degeneration across ancestries. Nature Genetics , 2024; 56 (12): 2659 DOI: 10.1038/s41588-024-01764 ...

Support LAist by giving now. Investigations are underway into the causes of the Eaton and Palisades fires — two of the most deadly wildfires in state history. But how, exactly, do people ...

Investigators are beginning their work to determine the origin and cause of huge fires in the Los Angeles area. The Palisades fire, the largest of three blazes still burning, may have been started ...

Investigators are beginning their work to determine the origin and cause of the devastating fires in Los Angeles. The work will likely take months, if not longer, as investigators consider a slew ...

macular edema caused by a blockage in the retinal vein diabetic retinopathy diabetic macular edema Eylea is also used to treat retinopathy of prematurity, an eye condition that can affect ...